Association of fat-free mass index and survival in patients with lung cancer: a multicenter cohort study.
[BACKGROUND] Fat-free mass index (FFMI) is a prognostic influence in cancer patients.
- p-value P < 0.001
- 95% CI 1.12-1.49
- HR 1.29
- 추적기간 41.0 months
APA
Zhang G, Xu H, et al. (2026). Association of fat-free mass index and survival in patients with lung cancer: a multicenter cohort study.. International journal of clinical oncology, 31(1), 97-106. https://doi.org/10.1007/s10147-025-02929-5
MLA
Zhang G, et al.. "Association of fat-free mass index and survival in patients with lung cancer: a multicenter cohort study.." International journal of clinical oncology, vol. 31, no. 1, 2026, pp. 97-106.
PMID
41288932
Abstract
[BACKGROUND] Fat-free mass index (FFMI) is a prognostic influence in cancer patients. However, for the prognosis of Chinese lung cancer (LC) patients, the threshold and impact of FFMI are not known. The aim of the present study was to examine the association between FFMI and the prognosis of Chinese patients with LC.
[METHODS] Totally 1,881 adult patients with LC were enrolled. During a median follow-up of 41.0 months (range 23.8-64.3), we reported 938 deaths. The optimal stratification method was used to determine the gender-specific optimal threshold for FFMI. Cox regression model and Kaplan-Meier curve were used to evaluate the relationship between FFMI and prognosis. Mediation analysis was used to determine the mediating effect of inflammation.
[RESULTS] The optimal cutoff points for low FFMI in males and females were 17.27 kg/m and 14.84 kg/m, respectively. Low FFMI was an independent prognostic indicator for LC patients. Patients who experienced a low FFMI were 29% more likely to die than patients who did not have a low FFMI (P < 0.001, HR = 1.29, 95%CI: 1.12-1.49). The impact of low FFMI on prognosis in LC patients exhibited significant staging dependence, particularly in advanced non-small cell LC and extensive-stage small cell LC. NLR mediated 9.2% of the associations between FFMI and LC all-cause mortality.
[CONCLUSION] In this prospective study, low FFMI, as determined by cutoff values, was an independent prognostic factor for patients with LC in both males and females. The association between FFMI and LC prognosis was significantly mediated by NLR.
[METHODS] Totally 1,881 adult patients with LC were enrolled. During a median follow-up of 41.0 months (range 23.8-64.3), we reported 938 deaths. The optimal stratification method was used to determine the gender-specific optimal threshold for FFMI. Cox regression model and Kaplan-Meier curve were used to evaluate the relationship between FFMI and prognosis. Mediation analysis was used to determine the mediating effect of inflammation.
[RESULTS] The optimal cutoff points for low FFMI in males and females were 17.27 kg/m and 14.84 kg/m, respectively. Low FFMI was an independent prognostic indicator for LC patients. Patients who experienced a low FFMI were 29% more likely to die than patients who did not have a low FFMI (P < 0.001, HR = 1.29, 95%CI: 1.12-1.49). The impact of low FFMI on prognosis in LC patients exhibited significant staging dependence, particularly in advanced non-small cell LC and extensive-stage small cell LC. NLR mediated 9.2% of the associations between FFMI and LC all-cause mortality.
[CONCLUSION] In this prospective study, low FFMI, as determined by cutoff values, was an independent prognostic factor for patients with LC in both males and females. The association between FFMI and LC prognosis was significantly mediated by NLR.
MeSH Terms
Humans; Female; Male; Lung Neoplasms; Middle Aged; Aged; Prognosis; Body Mass Index; Adult; Cohort Studies; Aged, 80 and over; Kaplan-Meier Estimate; China
같은 제1저자의 인용 많은 논문 (5)
- Isomers of 2,2':6',2″-terpyridine and 2,6-dipyrazin-2-ylpyridine with aliphatic substituents: synthesis, coordination chemistry, and catalytic and anticancer activities.
- Nanoreagents Against the Blood-Testis Barrier: A Strategy for Diagnosing and Treating Male Reproductive System Diseases.
- Bibliometric analysis of anti-angiogenic therapy in gastric cancer: research hotspots, trends, and emerging frontiers.
- M2 macrophages modulate the differentiation of CD8 + CD101-TIM3 + T cells via the SPP1‒CD44 pathway, influencing the immunotherapeutic response in NSCLC.
- A novel HEAT repeat protein 5B anaplastic lymphoma kinase fusion in lung adenocarcinoma confers sensitivity to ensartinib.